Key facts
- This page summarizes David A. Socks's Form 4 filing for Phathom Pharmaceuticals, Inc. (PHAT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2024, 19:14.
David A. Socks - 23 May 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)
- Reporting relationship
- Director
- Issuer ticker
- PHAT
- Reported as of
- 23 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 19:14:30 UTC
- Prior SEC filing
- 30 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Molly Henderson, Attorney-in-Fact for David A. Socks
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David A. Socks filed Form 4 for Phathom Pharmaceuticals, Inc. (PHAT) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 30 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHAT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,500
- Change %
- +117%
- Price
- $0.000000
- Shares after
- 19,500
- Date
- 23 May 2024
- Ownership
- Direct
- Footnotes
- F1
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,211,346
- Date
- 23 May 2024
- Ownership
- David A. Socks Family Trust
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 410
- Date
- 23 May 2024
- Ownership
- By 401(k)
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PHAT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- -17,500
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 17,500
- Date
- 23 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,500
- Exercise price
- $10.30
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Restricted Stock Units ("RSUs") were granted on May 23, 2024, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Footnote F2
The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.